Pancreatic Cancer Research

ResearcherJiangsu UniversityActive in the last 2 years

Dongqing Wang

Matched on ORCID iD 0000-0003-2801-3033; OpenAlex author ID A5100670776. Sources: OpenAlex.

Their work

Papers
8 (first author 2, last author 2)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2013: 2 papers · 2014: 1 paper · 2015: 1 paper · 2016: 1 paper · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 8

  1. SREBP1-SCD1 enhanced MUFAs Biosynthesis drives Nutrient Deprived Pancreatic cancer cell Ferroptosis Resistance. Last author DOI 10.7150/jca.114356↗
  2. Differently PEGylated Polymer Nanoparticles for Pancreatic Cancer Delivery: Using a Novel Near-Infrared Emissive and Biodegradable Polymer as the Fluorescence … Co-author DOI 10.3389/fbioe.2021.699610↗
  3. Retraction notice to "CD133+/CD44+/Oct4+/Nestin+ stem-like cells isolated from Panc-1 cell line may contribute to multi-resistance and metastasis of pancreatic… Co-author DOI 10.1016/j.acthis.2018.03.005↗
  4. CCL21/CCR7 Axis Contributed to CD133+ Pancreatic Cancer Stem-Like Cell Metastasis via EMT and Erk/NF-κB Pathway. First author DOI 10.1371/journal.pone.0158529↗
  5. [CCL21 promotes the metastasis of human pancreatic cancer Panc-1 cells via epithelial- mesenchymal transition]. Last author PMID 25575049↗
  6. The low chamber pancreatic cancer cells had stem-like characteristics in modified transwell system: is it a novel method to identify and enrich cancer stem-lik… Co-author DOI 10.1155/2014/760303↗
  7. CD133(+)/CD44(+)/Oct4(+)/Nestin(+) stem-like cells isolated from Panc-1 cell line may contribute to multi-resistance and metastasis of pancreatic cancer. Co-author DOI 10.1016/j.acthis.2012.09.007↗
  8. Role of the Hypoxia-inducible factor-1 alpha induced autophagy in the conversion of non-stem pancreatic cancer cells into CD133+ pancreatic cancer stem-like ce… First author DOI 10.1186/1475-2867-13-119↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Haitao Zhu · 6 shared papers, 2013–2018 · strength 0.31
  2. Aihua Gong · 1 shared paper, 2025 · strength 0.28
  3. Zhengyang Zhang · 1 shared paper, 2025 · strength 0.28
  4. Yanfang Liu · 5 shared papers, 2013–2018 · strength 0.25
  5. Zhaoliang Su · 5 shared papers, 2013–2018 · strength 0.25
  6. Huazhong Cai · 1 shared paper, 2021 · strength 0.14
  7. Zhimin Tao · 1 shared paper, 2021 · strength 0.14
  8. Lirong Zhang · 2 shared papers, 2014–2016 · strength 0.10
  9. Qing Liu · 2 shared papers, 2014–2015 · strength 0.09
  10. Jianxin Zhang · 1 shared paper, 2016 · strength 0.05
  11. Genbao Shao · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.